Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Executives
Pharma
Jazz reviewing M&A deal options of 'various sizes,' CFO says
Jazz Pharma has “significant financial resources […] to engage in M&A and licensing activities for the various sizes,” its CFO said on Tuesday.
Angus Liu
Feb 26, 2025 11:08am
Novartis, Roche give their CEOs pay raises in 2024
Feb 19, 2025 10:55am
How J&J CEO broke a stalemate and won Intra-Cellular in M&A push
Feb 7, 2025 11:24am
AstraZeneca logs China sales decline in Q4 amid probes
Feb 6, 2025 10:31am
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
Moderna CEO confronts challenges for RSV, COVID businesses
Jan 7, 2025 11:00am
